{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:22:26Z","timestamp":1761092546719,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12350-015-0070-2","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T14:52:35Z","timestamp":1424357555000},"page":"1262-1268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy"],"prefix":"10.1016","volume":"22","author":[{"given":"O.","family":"Asghar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.S.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.G.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-015-0070-2_bib1","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2337\/diabetes.52.12.2867","article-title":"Microvascular complications of impaired glucose tolerance","volume":"52","author":"Singleton","year":"2003","journal-title":"Diabetes"},{"key":"10.1007\/s12350-015-0070-2_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","article-title":"Pre-diabetes and the risk for cardiovascular disease","volume":"55","author":"Ford","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0070-2_bib3","doi-asserted-by":"crossref","unstructured":"Levitzky YS, Pencina MJ, D\u2019Agostino RB, Meigs JB, Murabito JM, Vasan RS, et al. Impact of impaired fasting glucose on cardiovascular disease: The Framingham heart study. J Am Coll Cardiol 2008;51:264-70.","DOI":"10.1016\/j.jacc.2007.09.038"},{"key":"10.1007\/s12350-015-0070-2_bib4","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/archinte.164.19.2147","article-title":"Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies","volume":"164","author":"Levitan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1007\/s12350-015-0070-2_bib5","doi-asserted-by":"crossref","unstructured":"Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sex-related differences in the Framingham heart study. Circulation 2003;107:448-54. doi:10.1161\/01.CIR.0000045671.62860.98.","DOI":"10.1161\/01.CIR.0000045671.62860.98"},{"key":"10.1007\/s12350-015-0070-2_bib6","unstructured":"Henry RMA, Paulus WJ, Kamp O, Kostense PJ, Spijkerman AMW, Dekker JM, et al. Deteriorating glucose tolerance status is associated with left ventricular dysfunction\u2014The Hoorn study. Neth J Med 2008;66:110-7."},{"key":"10.1007\/s12350-015-0070-2_bib7","doi-asserted-by":"crossref","unstructured":"Henry RMA, Kamp O, Kostense PJ, Spijkerman AMW, Dekker JM, van Eijck R, et al. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: Independence of increased arterial stiffness or decreased flow-mediated dilation. Diabetes Care 2004;27:522.","DOI":"10.2337\/diacare.27.2.522"},{"key":"10.1007\/s12350-015-0070-2_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2007.10.021","article-title":"Insulin-resistant cardiomyopathy: Clinical evidence, mechanisms, and treatment options","volume":"51","author":"Witteles","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0070-2_bib9","doi-asserted-by":"crossref","unstructured":"Velagaleti RS, Gona P, Chuang ML, Salton CJ, Fox CS, Blease SJ, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: The Framingham heart study. Circ Cardiovasc Imaging 2010;3:257-63. doi:10.1161\/CIRCIMAGING.109.911438.","DOI":"10.1161\/CIRCIMAGING.109.911438"},{"key":"10.1007\/s12350-015-0070-2_bib10","doi-asserted-by":"crossref","unstructured":"Okura H, Inoue H, Tomon M, Nishiyama S, Yoshikawa T, Yoshida K, et al. Impaired glucose tolerance as a determinant of early deterioration of left ventricular diastolic function in middle-aged healthy subjects. Am J Cardiol 2000;85:790.","DOI":"10.1016\/S0002-9149(99)00866-8"},{"key":"10.1007\/s12350-015-0070-2_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1067\/mhj.2001.115302","article-title":"Relationship of impaired glucose tolerance to left ventricular structure and function: The strong heart study","volume":"141","author":"Ilercil","year":"2001","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0070-2_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/heart.85.6.643","article-title":"A comparison of left ventricular abnormalities associated with glucose intolerance in African Caribbeans and Europeans in the UK","volume":"85","author":"Chaturvedi","year":"2001","journal-title":"Heart"},{"key":"10.1007\/s12350-015-0070-2_bib13","doi-asserted-by":"crossref","unstructured":"Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010;33:1578-84. doi:10.2337\/dc10-0125.","DOI":"10.2337\/dc10-0125"},{"key":"10.1007\/s12350-015-0070-2_bib14","doi-asserted-by":"crossref","unstructured":"Putz Z, Tabak AG, Toth N, Istenes I, Nemeth N, Gandhi RA, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009;32:181-3. doi:10.2337\/dc08-1406.","DOI":"10.2337\/dc08-1406"},{"key":"10.1007\/s12350-015-0070-2_bib15","doi-asserted-by":"crossref","unstructured":"Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study. Diabet Med 2007;24:855-63. doi:10.1111\/j.1464-5491.2007.02163.x.","DOI":"10.1111\/j.1464-5491.2007.02163.x"},{"key":"10.1007\/s12350-015-0070-2_bib16","doi-asserted-by":"crossref","unstructured":"Asghar O, Petropoulos IN, Alam U, Jones W, Jeziorska M, Marshall A, et al. Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care 2014;37:2643-6. doi:10.2337\/dc14-0279.","DOI":"10.2337\/dc14-0279"},{"key":"10.1007\/s12350-015-0070-2_bib17","doi-asserted-by":"crossref","unstructured":"Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, et al. Neuroadrenergic dysfunction along the diabetes continuum: A comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-16. doi:10.2337\/db12-0138.","DOI":"10.2337\/db12-0138"},{"key":"10.1007\/s12350-015-0070-2_bib18","doi-asserted-by":"crossref","unstructured":"Boogers MJ, Borleffs CJW, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77. doi:10.1016\/j.jacc.2009.12.066.","DOI":"10.1016\/j.jacc.2009.12.066"},{"key":"10.1007\/s12350-015-0070-2_bib19","doi-asserted-by":"crossref","unstructured":"Carri\u00f3 I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JCMG 2011;3:92-100. doi:10.1016\/j.jcmg.2009.07.014.","DOI":"10.1016\/j.jcmg.2009.07.014"},{"key":"10.1007\/s12350-015-0070-2_bib20","doi-asserted-by":"crossref","unstructured":"Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J 2008;29:1147-59. doi:10.1093\/eurheartj\/ehn113.","DOI":"10.1093\/eurheartj\/ehn113"},{"key":"10.1007\/s12350-015-0070-2_bib21","doi-asserted-by":"crossref","unstructured":"Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med 2008;49:907-14. doi:10.2967\/jnumed.107.047548.","DOI":"10.2967\/jnumed.107.047548"},{"key":"10.1007\/s12350-015-0070-2_bib22","doi-asserted-by":"crossref","unstructured":"Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parizek P, Agostini D, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: A prospective multicenter pilot study. Circ Cardiovasc Imaging 2008;1:131-40. doi:10.1161\/CIRCIMAGING.108.782433.","DOI":"10.1161\/CIRCIMAGING.108.782433"},{"key":"10.1007\/s12350-015-0070-2_bib23","unstructured":"Hattori N, Tamaki N, Hayashi T, Masuda I, Kudoh T, Tateno M, et al. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996;37:1985-90."},{"key":"10.1007\/s12350-015-0070-2_bib24","doi-asserted-by":"crossref","unstructured":"Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, et al. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 2011;4:87-93. doi:10.1161\/CIRCIMAGING.110.954784.","DOI":"10.1161\/CIRCIMAGING.110.954784"},{"key":"10.1007\/s12350-015-0070-2_bib25","doi-asserted-by":"crossref","unstructured":"Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 2006;13:34-42. doi:10.1016\/j.nuclcard.2005.11.009.","DOI":"10.1016\/j.nuclcard.2005.11.009"},{"key":"10.1007\/s12350-015-0070-2_bib26","doi-asserted-by":"crossref","unstructured":"Sacre JW, Franjic B, Jellis CL, SJenkins C, Coombes JS, Marwick TH. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging 2010;3:1207-15. doi:10.1016\/j.jcmg.2010.09.014.","DOI":"10.1016\/j.jcmg.2010.09.014"},{"key":"10.1007\/s12350-015-0070-2_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/dmrr.220","article-title":"Cardiac sympathetic innervation and blood flow regulation of the diabetic heart","volume":"17","author":"Schnell","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1007\/s12350-015-0070-2_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1464-5491.2003.00939.x","article-title":"Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients","volume":"20","author":"Hattori","year":"2003","journal-title":"Diabet Med"},{"key":"10.1007\/s12350-015-0070-2_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0070-2_bib30","doi-asserted-by":"crossref","unstructured":"Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 1996;45:801-5.","DOI":"10.2337\/diabetes.45.6.801"},{"key":"10.1007\/s12350-015-0070-2_bib31","doi-asserted-by":"crossref","unstructured":"Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, Standl E. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 1995;38:1345-52.","DOI":"10.1007\/s001250050433"},{"key":"10.1007\/s12350-015-0070-2_bib32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0735-1097(94)00459-4","article-title":"Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia","volume":"25","author":"Langer","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0070-2_bib33","doi-asserted-by":"crossref","unstructured":"Kreiner G, Wolzt M, Fasching P, Leitha T, Edlmayer A, Korn A, et al. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 1995;44:543-9.","DOI":"10.2337\/diabetes.44.5.543"},{"key":"10.1007\/s12350-015-0070-2_bib34","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, et al. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk. Circulation 1998;98:961-8. doi:10.1161\/01.CIR.98.10.961.","DOI":"10.1161\/01.CIR.98.10.961"},{"key":"10.1007\/s12350-015-0070-2_bib35","doi-asserted-by":"crossref","unstructured":"Diakakis G, Parthenakis F, Patrianakos A, Koukouraki SI, Stathaki MI, Karkavitsas NS, et al. Myocardial sympathetic innervation in patients with impaired glucose tolerance: Relationship to subclinical inflammation. Cardiovasc Pathol 2008;17:172-7.","DOI":"10.1016\/j.carpath.2007.07.007"},{"key":"10.1007\/s12350-015-0070-2_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0002-8703(93)91056-K","article-title":"Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy","volume":"126","author":"Gill","year":"1993","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0070-2_bib37","unstructured":"Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995;36:969-74."},{"key":"10.1007\/s12350-015-0070-2_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nuclcard.2003.10.010","article-title":"Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: Implications for clinical studies","volume":"11","author":"Somsen","year":"2004","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0070-2_bib39","first-page":"49","article-title":"Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects","volume":"38","author":"Morozumi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-015-0070-2_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCRESAHA.111.257253","article-title":"Development, maturation, and transdifferentiation of cardiac sympathetic nerves","volume":"110","author":"Kimura","year":"2012","journal-title":"Circ Res"},{"key":"10.1007\/s12350-015-0070-2_bib41","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-015-0070-2_bib42","first-page":"BP132","article-title":"131I\/123I-metaiodobenzylguanidine (MIBG) scintigraphy: Procedure guidelines for tumour imaging","volume":"30","author":"Bombardieri","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-015-0070-2_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12350-008-9008-2","article-title":"123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials","volume":"16","author":"Jacobson","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0070-2_bib44","doi-asserted-by":"crossref","unstructured":"Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanish Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol 2014;21:970-8. doi:10.1007\/s12350-014-9916-2.","DOI":"10.1007\/s12350-014-9916-2"},{"key":"10.1007\/s12350-015-0070-2_bib45","doi-asserted-by":"crossref","unstructured":"Verberne HJ, Habraken JBA, van Eck-Smit BLF, Agostini D, Jacobson AF. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: A need for standardisation and validation. Eur J Nucl Med Mol Imaging 2008;35:547-53. doi:10.1007\/s00259-007-0611-2.","DOI":"10.1007\/s00259-007-0611-2"},{"key":"10.1007\/s12350-015-0070-2_bib46","doi-asserted-by":"crossref","unstructured":"Isak B, Oflazoglu B, Tanridag T, Yitmen I, Us O. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 2008;24:563-9. doi:10.1002\/dmrr.859.","DOI":"10.1002\/dmrr.859"},{"key":"10.1007\/s12350-015-0070-2_bib47","doi-asserted-by":"crossref","unstructured":"Putz Z, Nemeth N, Istenes I, T Martos, Gandhi RA, K\u00f6rei AE, et al. Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance. Diabet Med 2013;30:358-62. doi:10.1111\/dme.12111.","DOI":"10.1111\/dme.12111"},{"key":"10.1007\/s12350-015-0070-2_bib48","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/diacare.23.6.826","article-title":"Is there a glycemic threshold for impaired autonomic control?","volume":"23","author":"Watkins","year":"2000","journal-title":"Diabetes Care"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-015-0070-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123071842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123071842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0070-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:57:01Z","timestamp":1761026221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123071842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1071358123071842"],"URL":"https:\/\/doi.org\/10.1007\/s12350-015-0070-2","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-015-0070-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}